These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37375013)

  • 21. Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.
    McAulay K; Saito K; Warrier T; Walsh KF; Mathurin LD; Royal-Mardi G; Lee MH; Ocheretina O; Pape JW; Fitzgerald DW; Nathan CF
    mBio; 2018 Nov; 9(6):. PubMed ID: 30459198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of slow recovery of Mycobacterium africanum-infected patients posttreatment with high content of Persister-Like bacilli in pretreatment sputum.
    Tientcheu LD; Bell A; Secka O; Ayorinde A; Otu J; Garton NJ; Sutherland JS; Ota MO; Antonio M; Dockrell HM; Kampmann B; Barer MR
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S99-S100. PubMed ID: 28043641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic Profiling Reveals the Architecture of Granulomatous Lesions Caused by Tuberculosis and
    Seto S; Morimoto K; Yoshida T; Hiramatsu M; Hijikata M; Nagata T; Kikuchi F; Shiraishi Y; Kurashima A; Keicho N
    Front Microbiol; 2019; 10():3081. PubMed ID: 32010116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis.
    Dannenberg AM
    Immunobiology; 1994 Oct; 191(4-5):461-73. PubMed ID: 7713560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delamanid Kills Dormant Mycobacteria
    Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of
    Khan MZ; Nandicoori VK
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis.
    Irwin SM; Driver E; Lyon E; Schrupp C; Ryan G; Gonzalez-Juarrero M; Basaraba RJ; Nuermberger EL; Lenaerts AJ
    Dis Model Mech; 2015 Jun; 8(6):591-602. PubMed ID: 26035867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Differentially Detectable Mycobacterium tuberculosis in the Sputum of Subjects with Drug-Sensitive or Drug-Resistant Tuberculosis before and after Two Months of Therapy.
    Zainabadi K; Walsh KF; Vilbrun SC; Mathurin LD; Lee MH; Saito K; Mishra S; Ocheretina O; Pape JW; Nathan C; Fitzgerald DW
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0060821. PubMed ID: 34060896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model.
    Ramey ME; Kaya F; Bauman AA; Massoudi LM; Sarathy JP; Zimmerman MD; Scott DWL; Job AM; Miller-Dawson JA; Podell BK; Lyons MA; Dartois V; Lenaerts AJ; Robertson GT
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0059723. PubMed ID: 37791784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing.
    Dannenberg AM; Dey B
    Vaccines (Basel); 2013 Jan; 1(1):58-76. PubMed ID: 26343850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update.
    Njire M; Tan Y; Mugweru J; Wang C; Guo J; Yew W; Tan S; Zhang T
    Adv Med Sci; 2016 Mar; 61(1):63-71. PubMed ID: 26521205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
    Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
    PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.
    Driver ER; Ryan GJ; Hoff DR; Irwin SM; Basaraba RJ; Kramnik I; Lenaerts AJ
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3181-95. PubMed ID: 22470120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment.
    Hoff DR; Ryan GJ; Driver ER; Ssemakulu CC; De Groote MA; Basaraba RJ; Lenaerts AJ
    PLoS One; 2011 Mar; 6(3):e17550. PubMed ID: 21445321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions.
    Sarathy JP; Liang HH; Weiner D; Gonzales J; Via LE; Dartois V
    J Vis Exp; 2017 May; (123):. PubMed ID: 28518128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between sterilizing activity and drug distribution into tuberculosis lesions.
    Prideaux B; Via LE; Zimmerman MD; Eum S; Sarathy J; O'Brien P; Chen C; Kaya F; Weiner DM; Chen PY; Song T; Lee M; Shim TS; Cho JS; Kim W; Cho SN; Olivier KN; Barry CE; Dartois V
    Nat Med; 2015 Oct; 21(10):1223-7. PubMed ID: 26343800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas.
    Irwin SM; Gruppo V; Brooks E; Gilliland J; Scherman M; Reichlen MJ; Leistikow R; Kramnik I; Nuermberger EL; Voskuil MI; Lenaerts AJ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4026-34. PubMed ID: 24798275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.